7.20
전일 마감가:
$7.26
열려 있는:
$7.19
하루 거래량:
2.39M
Relative Volume:
0.32
시가총액:
$1.14B
수익:
$2.59B
순이익/손실:
$-981.73M
주가수익비율:
-1.2478
EPS:
-5.77
순현금흐름:
$206.95M
1주 성능:
+5.42%
1개월 성능:
-16.67%
6개월 성능:
-15.99%
1년 성능:
-45.99%
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
2 MANHATTANVILLE ROAD, PURCHASE, NY
TDOC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TDOC
Teladoc Health Inc
|
7.20 | 1.14B | 2.59B | -981.73M | 206.95M | -5.77 |
![]()
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-15 | 개시 | Goldman | Buy |
2024-09-17 | 재확인 | Jefferies | Hold |
2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
2024-02-26 | 개시 | Leerink Partners | Market Perform |
2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
2024-01-03 | 개시 | Barclays | Overweight |
2023-04-12 | 개시 | Stephens | Equal-Weight |
2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | 개시 | Truist | Hold |
2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
2022-08-12 | 개시 | DA Davidson | Buy |
2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
2022-07-06 | 재확인 | BofA Securities | Neutral |
2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2022-04-07 | 개시 | Guggenheim | Buy |
2022-04-01 | 재개 | Credit Suisse | Outperform |
2022-03-03 | 업그레이드 | Argus | Hold → Buy |
2022-02-23 | 재확인 | BofA Securities | Neutral |
2022-02-23 | 재확인 | Craig Hallum | Hold |
2022-02-23 | 재확인 | Evercore ISI | In-line |
2022-02-23 | 재확인 | Goldman | Buy |
2022-02-23 | 재확인 | JP Morgan | Overweight |
2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
2022-02-23 | 재확인 | Needham | Buy |
2022-02-23 | 재확인 | Oppenheimer | Outperform |
2022-02-23 | 재확인 | Stifel | Hold |
2022-02-11 | 개시 | Goldman | Buy |
2022-02-08 | 재확인 | Piper Sandler | Overweight |
2021-12-02 | 재개 | Jefferies | Hold |
2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
2021-10-28 | 재확인 | Barclays | Equal Weight |
2021-10-28 | 재확인 | BofA Securities | Neutral |
2021-10-28 | 재확인 | Canaccord Genuity | Buy |
2021-10-28 | 재확인 | Citigroup | Buy |
2021-10-28 | 재확인 | Craig Hallum | Hold |
2021-10-28 | 재확인 | Needham | Buy |
2021-10-28 | 재확인 | Oppenheimer | Outperform |
2021-10-28 | 재확인 | Piper Sandler | Overweight |
2021-10-28 | 재확인 | UBS | Neutral |
2021-10-19 | 개시 | Wells Fargo | Overweight |
2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2021-05-28 | 개시 | Robert W. Baird | Neutral |
2021-04-15 | 개시 | Needham | Buy |
2021-01-07 | 개시 | BTIG Research | Buy |
2020-12-22 | 개시 | Evercore ISI | In-line |
2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2020-12-04 | 개시 | Goldman | Neutral |
2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2020-09-22 | 개시 | DA Davidson | Buy |
2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2020-07-14 | 개시 | Citigroup | Buy |
2020-07-13 | 개시 | Argus | Buy |
2020-07-07 | 개시 | Stephens | Overweight |
2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
2020-04-13 | 개시 | SVB Leerink | Outperform |
2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-01-10 | 개시 | UBS | Neutral |
2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
Citi Revises Teladoc (TDOC) Price Target Amidst Cautious Outlook - GuruFocus
To Register Unwavering Growth Of Remote Medical Expert - openPR.com
Teladoc Health (NYSE:TDOC) Shares Fall 10% Over The Past Week - Yahoo Finance
Teladoc (TDOC) Experiences Surge in Bullish Option Activity | TDOC Stock News - GuruFocus
Digital Health In The Neurology Market Focusing On A Series - openPR.com
Chronic Disease Management Market Is Booming So Rapidly - openPR.com
U.S. Digital Mental Health Market New Product Development & Latest Trends | Teladoc Health,BetterHelp,Talkspace - openPR.com
Is Teladoc Health (TDOC) the Best Telehealth Stock to Buy Now? - Insider Monkey
Teladoc Health (TDOC) to Announce Q1 2025 Earnings on April 30 - GuruFocus
10 Best Telehealth Stocks to Buy Now - Insider Monkey
Jefferies cuts Teladoc price target to $8, maintains hold rating By Investing.com - Investing.com India
Jefferies cuts Teladoc price target to $8, maintains hold rating - Investing.com
Teladoc stock plunges to 52-week low, hits $6.61 By Investing.com - Investing.com India
Jefferies Lowers Teladoc (TDOC) Price Target Amid Declining Data Trends | TDOC Stock News - GuruFocus
Teladoc stock plunges to 52-week low, hits $6.61 - Investing.com
Emerging Trends in Telemedicine Second Opinion Solutions - openPR.com
Forecasting the Future: Healthcare Convenience Services - openPR.com
Telehealth Market Size to Reach USD 791.04 billion by 2032, Growing at CAGR of 22.9%NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Telestroke Services Market Set to Witness Significant Growth by 2025-2032 | ScienceSoft, SEVARO, Teladoc Health - openPR.com
Teladoc Health to Announce First Quarter 2025 Financial Results - GuruFocus
Teladoc Health to Announce First Quarter 2025 Financial Results | TDOC Stock News - GuruFocus
Teladoc Health Inc. to Release First Quarter 2025 Results on April 30, 2025 - Nasdaq
Virtual Care Leader Teladoc Health Sets Q1 2025 Earnings Release DateKey Details Inside - Stock Titan
Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade) (NYSE:TDOC) - Seeking Alpha
Emerging Trends in Video Consultation Medical Service Market - openPR.com
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - TradingView
Future Scope of Virtual Healthcare Home Market to Observe - openPR.com
Virtual Care Services Market Projected To Witness Massive - openPR.com
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction - MSN
Teladoc (TDOC) Experiences Increased Option Activity Ahead of Ea - GuruFocus
BofA Revises Teladoc (TDOC) Price Target Amid Weaker Growth and Strategic Initiatives | TDOC Stock News - GuruFocus
Forecasting The Future: 8 Analyst Projections For Teladoc Health - Benzinga
Lobbying Update: $10,000 of TELADOC HEALTH INC. lobbying was just disclosed - Nasdaq
Teladoc Health Launches New Cardiometabolic Health Program - MedCity News
Unparalleled Research on Behavioral Health Telehealth Market - openPR.com
Digital Health Market Projected To Witness Substantial Growth, - openPR.com
Teladoc (TDOC) Stock Moves -0.97%: What You Should Know - Yahoo Finance
Teladoc Health CFO Murthy Mala sells $51,011 in stock By Investing.com - Investing.com South Africa
Teladoc Health CFO Murthy Mala sells $51,011 in stock - Investing.com
Trend Tracker for (TDOC) - news.stocktradersdaily.com
Teladoc unveils virtual care tool for cardiometabolic health - TechTarget
Digital health startup Transcarent takes Accolade private in $621 million deal - CNBC
Teladoc Health Introduces Next Generation Cardiometabolic Health Program - GlobeNewswire
Revolutionary: New Teladoc Health Program Achieves 58% Diabetes Remission Levels - Stock Titan
Teladoc Stock Plummets to 52-Week Low of $6.76 Amid Market Challenges - Investing.com India
Teladoc Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights – TDOC - ACCESS Newswire
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? - AOL.com
Major Player in the Teletherapy Platform Integration Market - openPR.com
Teladoc (TDOC) Gains But Lags Market: What You Should Know - Yahoo Finance
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):